United Therapeutics Corp. (UTHR) PT Lowered to $103 at UBS
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $544.33 --0%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 5 | New: 16
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 5 | New: 16
Join SI Premium – FREE
UBS lowered its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $103.00 (from $108.00) while maintaining a Sell rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Downgrades Flowserve Corp. (FLS) to Hold
- Pennon Group Plc. (PNN:LN) (PEGRF) PT Lowered to GBP6.50 at Morgan Stanley
- Skandinaviska Enskilda Banken AB (SEBA:SS) (SKVKY) PT Lowered to SEK171 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
